- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/39 - PancreasIslets of Langerhans
Patent holdings for IPC class A61K 35/39
Total number of patents in this class: 936
10-year publication summary
|
73
|
78
|
94
|
81
|
76
|
89
|
76
|
73
|
59
|
67
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1578 |
45 |
| ViaCyte, Inc. | 180 |
38 |
| Children's Medical Center Corporation | 1978 |
29 |
| Janssen Biotech, Inc. | 1798 |
23 |
| Sana Biotechnology, Inc. | 185 |
23 |
| President and Fellows of Harvard College | 6118 |
21 |
| The Regents of the University of California | 20960 |
20 |
| City of Hope | 1050 |
17 |
| CRISPR Therapeutics AG | 373 |
16 |
| Massachusetts Institute of Technology | 10322 |
15 |
| Cornell University | 3456 |
13 |
| Seraxis, Inc. | 21 |
12 |
| Regents of the University of Minnesota | 2820 |
11 |
| Wake Forest University Health Sciences | 737 |
10 |
| Yeda Research and Development Co. Ltd. | 1392 |
10 |
| Kyoto University | 2947 |
9 |
| The Salk Institute for Biological Studies | 452 |
9 |
| University of Louisville Research Foundation, Inc. | 741 |
9 |
| The Board of Trustees of the Leland Stanford Junior University | 6724 |
8 |
| Accelerated Biosciences Corp. | 33 |
8 |
| Other owners | 590 |